SB

Shreyans Baldevbhai Shah

Active Director Director DIN 10731239
DIN 10731239 First appointment Aug 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Shreyans Baldevbhai Shah

Data last updated:

Shreyans Baldevbhai Shah is a Director at Vidanueva Pharma Private Limited (since 2024). The company operates in Paper.

DIN 10731239
Primary Designation Director
Industry Paper
First Appointment 05 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vidanueva Pharma Private Limited U21001GJ2024PTC154112
Director05 Aug 20242024Active

Board colleagues of Shreyans Baldevbhai Shah

NameDINCompanyDesignation
Bhavnaben Baldevbhai Solanki08375930Vidanueva Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vidanueva Pharma Private Limited
Premium access

Shareholding and investment profile for Shreyans Baldevbhai Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shreyans Baldevbhai Shah

Shreyans Baldevbhai Shah currently holds 1 directorship: Vidanueva Pharma Private Limited (Director, since 05 Aug 2024).

Shreyans Baldevbhai Shah was first appointed on 05 Aug 2024 as Director at Vidanueva Pharma Private Limited.

The current boards of Shreyans Baldevbhai Shah's companies include Bhavnaben Baldevbhai Solanki (Vidanueva Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available